Personalized medicine in oncology: the future is now
Related Experiment Video
Updated: Jun 13, 2026

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Published on: February 23, 2024
1Comprehensive Cancer Center, University of Chicago, 5841 South Maryland Avenue, MC 2115, Chicago, IL 60637, USA. rschilsk@medicine.bsd.uchicago.edu
Abstract:
Cancer chemotherapy is in evolution from non-specific cytotoxic drugs that damage both tumour and normal cells to more specific agents and immunotherapy approaches. Targeted agents are directed at unique molecular features of cancer cells, and immunotherapeutics modulate the tumour immune response; both approaches aim to produce greater effectiveness with less toxicity. The development and use of such agents in biomarker-defined populations enables a more personalized approach to cancer treatment than previously possible and has the potential to reduce the cost of cancer care.
Insights
Cancer treatment is shifting from general chemotherapy to targeted therapies and immunotherapies. These advanced approaches offer greater effectiveness and reduced toxicity for patients, enabling personalized cancer care.
Area of Science:
- Oncology
- Pharmacology
Background:
- Traditional cancer chemotherapy utilizes non-specific cytotoxic drugs impacting both cancerous and healthy cells.
- This broad toxicity necessitates the development of more refined therapeutic strategies.
Approach:
- The evolution of cancer treatment involves targeted agents and immunotherapy.
- Targeted agents focus on specific molecular characteristics of cancer cells.
- Immunotherapeutics aim to modulate the patient's immune response against the tumor.
Key Points:
- Both targeted agents and immunotherapies are designed for increased efficacy and reduced side effects.
- The use of these advanced treatments is increasingly linked to specific biomarkers.
- This biomarker-defined approach facilitates personalized cancer treatment strategies.
Conclusions:
- Personalized medicine in oncology represents a significant advancement over previous treatment paradigms.
- These novel therapeutic strategies hold the potential to improve patient outcomes and decrease healthcare costs.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

